Wednesday, June 30, 2021 4:36:37 PM
My associate who sold a biotech company to Becton Dickinson and now heads a top 100 crypto project did me a favor and Dialed the IR today he owns a boatload of Hepa shares.
His takeaways from his conversation with IR
Clinical portion of dosing/treatment has been completed!
Data collection has been compiled and top line results will be released sooner than later these things take time to put together!
Should be in the coming days. No official time set, but releasing in the near future!
Top line results will be released and then further data analysis will take place after the release 75mg data was great, 150mg & 225mg data will determine optimal dosage moving forward All about determining patient safety on dosing!
Besides that if you do your homework with laser like focus you know there is a myriad of catalyst about to drop!
HEPA similar pattern to ATOS 3 months ago chart before the price surge!!
$Hepa
His takeaways from his conversation with IR
Clinical portion of dosing/treatment has been completed!
Data collection has been compiled and top line results will be released sooner than later these things take time to put together!
Should be in the coming days. No official time set, but releasing in the near future!
Top line results will be released and then further data analysis will take place after the release 75mg data was great, 150mg & 225mg data will determine optimal dosage moving forward All about determining patient safety on dosing!
Besides that if you do your homework with laser like focus you know there is a myriad of catalyst about to drop!
HEPA similar pattern to ATOS 3 months ago chart before the price surge!!
$Hepa
Recent HEPA News
- Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma • GlobeNewswire Inc. • 03/03/2026 12:35:00 PM
- Hepion Pharmaceuticals Successfully Completes Application to the OTCQB • GlobeNewswire Inc. • 06/25/2025 12:30:00 PM
- Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer • GlobeNewswire Inc. • 06/16/2025 12:30:00 PM
